276 related articles for article (PubMed ID: 31771180)
1. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells.
Sarfstein R; Nagaraj K; LeRoith D; Werner H
Cells; 2019 Nov; 8(12):. PubMed ID: 31771180
[TBL] [Abstract][Full Text] [Related]
2. Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel.
ter Braak B; Siezen CL; Kannegieter N; Koedoot E; van de Water B; van der Laan JW
Arch Toxicol; 2014 Apr; 88(4):953-66. PubMed ID: 24464500
[TBL] [Abstract][Full Text] [Related]
3. Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns.
Sarfstein R; Yeheskel A; Sinai-Livne T; Pasmanik-Chor M; Werner H
Front Endocrinol (Lausanne); 2020; 11():435. PubMed ID: 32733384
[TBL] [Abstract][Full Text] [Related]
4. The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer.
Werner H; Sarfstein R; Laron Z
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33918477
[TBL] [Abstract][Full Text] [Related]
5. Human IGF1 pro-forms induce breast cancer cell proliferation via the IGF1 receptor.
De Santi M; Annibalini G; Barbieri E; Villarini A; Vallorani L; Contarelli S; Berrino F; Stocchi V; Brandi G
Cell Oncol (Dordr); 2016 Apr; 39(2):149-59. PubMed ID: 26701791
[TBL] [Abstract][Full Text] [Related]
6. Controlled dimerization of insulin-like growth factor-1 and insulin receptors reveals shared and distinct activities of holo and hybrid receptors.
Chen J; Nagle AM; Wang YF; Boone DN; Lee AV
J Biol Chem; 2018 Mar; 293(10):3700-3709. PubMed ID: 29330302
[TBL] [Abstract][Full Text] [Related]
7. Minireview: nuclear insulin and insulin-like growth factor-1 receptors: a novel paradigm in signal transduction.
Sarfstein R; Werner H
Endocrinology; 2013 May; 154(5):1672-9. PubMed ID: 23507573
[TBL] [Abstract][Full Text] [Related]
8. InsR/IGF1R Pathway Mediates Resistance to EGFR Inhibitors in Glioblastoma.
Ma Y; Tang N; Thompson RC; Mobley BC; Clark SW; Sarkaria JN; Wang J
Clin Cancer Res; 2016 Apr; 22(7):1767-76. PubMed ID: 26561558
[TBL] [Abstract][Full Text] [Related]
9. IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.
Li Z; Pan W; Shen Y; Chen Z; Zhang L; Zhang Y; Luo Q; Ying X
Cell Cycle; 2018; 17(10):1212-1219. PubMed ID: 29886785
[TBL] [Abstract][Full Text] [Related]
10. Loss of E-cadherin Enhances IGF1-IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR Inhibitors.
Nagle AM; Levine KM; Tasdemir N; Scott JA; Burlbaugh K; Kehm J; Katz TA; Boone DN; Jacobsen BM; Atkinson JM; Oesterreich S; Lee AV
Clin Cancer Res; 2018 Oct; 24(20):5165-5177. PubMed ID: 29941485
[No Abstract] [Full Text] [Related]
11. Inhibition of RPS6K reveals context-dependent Akt activity in luminal breast cancer cells.
Erdem C; Lee AV; Taylor DL; Lezon TR
PLoS Comput Biol; 2021 Jun; 17(6):e1009125. PubMed ID: 34191793
[TBL] [Abstract][Full Text] [Related]
12. Novel nuclear localization and potential function of insulin-like growth factor-1 receptor/insulin receptor hybrid in corneal epithelial cells.
Wu YC; Zhu M; Robertson DM
PLoS One; 2012; 7(8):e42483. PubMed ID: 22879999
[TBL] [Abstract][Full Text] [Related]
13. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway.
Tognon CE; Somasiri AM; Evdokimova VE; Trigo G; Uy EE; Melnyk N; Carboni JM; Gottardis MM; Roskelley CD; Pollak M; Sorensen PH
Cancer Res; 2011 Feb; 71(3):1060-70. PubMed ID: 21148487
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor (IGF) signaling requires αvβ3-IGF1-IGF type 1 receptor (IGF1R) ternary complex formation in anchorage independence, and the complex formation does not require IGF1R and Src activation.
Fujita M; Takada YK; Takada Y
J Biol Chem; 2013 Feb; 288(5):3059-69. PubMed ID: 23243309
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells.
Li Z; Levine KM; Bahreini A; Wang P; Chu D; Park BH; Oesterreich S; Lee AV
Endocrinology; 2018 Jan; 159(1):285-296. PubMed ID: 29029116
[TBL] [Abstract][Full Text] [Related]
16. A viral insulin-like peptide inhibits IGF-1 receptor phosphorylation and regulates IGF1R gene expression.
Chrudinová M; Kirk NS; Chuard A; Venugopal H; Zhang F; Lubos M; Gelfanov V; Páníková T; Žáková L; Cutone J; Mojares M; DiMarchi R; Jiráček J; Altindis E
Mol Metab; 2024 Feb; 80():101863. PubMed ID: 38182007
[TBL] [Abstract][Full Text] [Related]
17. The proximity-labeling technique BioID identifies sorting nexin 6 as a member of the insulin-like growth factor 1 (IGF1)-IGF1 receptor pathway.
Bareja A; Hodgkinson CP; Soderblom E; Waitt G; Dzau VJ
J Biol Chem; 2018 Apr; 293(17):6449-6459. PubMed ID: 29530981
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
Zhang H; Pelzer AM; Kiang DT; Yee D
Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
[TBL] [Abstract][Full Text] [Related]
19. The IGF1 Signaling Pathway: From Basic Concepts to Therapeutic Opportunities.
Werner H
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834331
[TBL] [Abstract][Full Text] [Related]
20. Alternative tyrosine phosphorylation of signaling kinases according to hormone receptor status in breast cancer overexpressing the insulin-like growth factor receptor type 1.
Ueda S; Tsuda H; Sato K; Takeuchi H; Shigekawa T; Matsubara O; Hiraide H; Mochizuki H
Cancer Sci; 2006 Jul; 97(7):597-604. PubMed ID: 16827799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
